Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. by Müller, J, Krijgsman, O, Tsoi, J, Robert, L, Hugo, W, Song, C, Kong, X, Possik, P, Cornelissen-Steijger, P, Foppen, M, Kemper, K, Goding, C, McDermott, U, Blank, C, Haanen, J, Graeber, T, Ribas, A, Lo, R, Peeper, D

An adverse tumor-protective effect of IDO1 inhibition by Kenski, JCN, Huang, X, Vredevoogd, DW, de Bruijn, B, Traets, JJH, Ibáñez-Molero, S, Schieven, SM, van Vliet, A, Krijgsman, O, Kuilman, T, Pozniak, J, Loayza-Puch, F, Terry, AM, Müller, J, Logtenberg, MEW, de Bruijn, M, Levy, P, Körner, P-R, Goding, CR, Schumacher, TN, Marine, J-C, Agami, R, Peeper, DS